浙江省2024年百日咳流行病学特征及住院情况分析
基于中国疾病预防控制信息系统和浙江省免疫规划智慧服务信息系统,收集2024年浙江省百日咳报告病例及百白破疫苗接种信息,采用描述性流行病学、Cochran-Armitage趋势检验和多因素logistic回归分析。结果显示2024年报告发病率90.42/10万,较2023年上升37.64倍,5~9岁儿童占63.00%;每多接种1剂DTP疫苗,住院风险降低约25%(aOR=0.75,95%CI:0.69~0.80)。
要点
- 2024年浙江省百日咳报告发病率90.42/10万,较2023年上升37.64倍。
- 5~9岁学龄儿童病例最多(63.00%),<1岁和老年人住院风险较高。
- 每多接种1剂DTP疫苗,住院风险降低约25%(aOR=0.75,95%CI:0.69~0.80)。
核心结论
- 浙江省2024年百日咳报告发病率大幅上升,5~9岁学龄儿童为主要发病人群。
- <1岁儿童和老年人发病后住院风险较高,完成更多剂次DTP接种可降低住院风险。
研究设计与样本
- 通过中国疾病预防控制信息系统和浙江省免疫规划智慧服务信息系统收集2024年1月1日至12月31日百日咳报告病例个案及DTP接种信息。
- 采用描述性流行病学方法分析流行病学特征和住院情况,用Cochran-Armitage趋势检验分析住院率随DTP剂次变化的趋势,多因素logistic回归探究DTP剂次与住院率的关系。
主要发现
- 2024年浙江省共报告百日咳病例59 917例,年报告发病率90.42/10万,较2023年(2.34/10万)上升37.64倍。
- 5~9岁组病例数最多(63.00%);<1岁组2 830例中3~5月龄婴儿最多(42.76%)。
- 2024年7月1日后报告7 826例中住院1 513例(19.33%),其中普通住院1 507例,重症监护6例(<1岁组5例)。
- 住院率随年龄组差异有统计学意义(P<0.001),≥81岁77.27%、71~80岁62.50%、<1岁56.20%,31~40岁最低5.78%。
- 随DTP接种剂次增加住院率呈下降趋势(Z=-20.33,P<0.001);调整年龄和性别后每多接种1剂DTP住院风险降低约25%(aOR=0.75,95%CI:0.69~0.80)。
关键数值与推荐
- 2024年浙江省百日咳年报告发病率90.42/10万,较2023年2.34/10万上升37.64倍。
- 5~9岁组占63.00%;<1岁组中3~5月龄占42.76%。
- 7月1日后报告病例住院率19.33%(1 513/7 826),重症监护6例。
- 年龄组住院率:≥81岁77.27%,71~80岁62.50%,<1岁56.20%,31~40岁5.78%(P<0.001)。
- 每多接种1剂DTP疫苗住院风险aOR=0.75(95%CI:0.69~0.80)。
临床怎么用
- 关注5~9岁学龄儿童百日咳发病,提高DTP疫苗接种率以降低住院风险。
- <1岁婴儿和老年人发病后住院风险高,应加强早期识别和医疗资源配置。
- 推动完成更多剂次DTP接种,作为降低百日咳住院风险的重要措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To describe the epidemiological characteristics and hospitalization status of pertussis in Zhejiang Province in 2024. Methods: Individual data on pertussis cases reported in Zhejiang Province from January 1 to December 31, 2024, and their diphtheria, tetanus, and pertussis (DTP) vaccination records were collected from the China Disease Prevention and Control Information System and the Zhejiang Provincial Intelligent Service Information System on Immunization Program. Descriptive epidemiological methods were used to analyze the epidemiological characteristics and hospitalization status of cases. The Cochran-Armitage trend test was employed to examine the trend in hospitalization rates with increasing number of DTP vaccine doses, and a multivariate logistic regression model was further used to explore the association between the number of DTP vaccine doses and the hospitalization rate of pertussis. Results: A total of 59 917 pertussis cases were reported in Zhejiang Province in 2024, with an annual reported incidence rate of 90.42 per 100 000 population, representing an increase of 37.64 times compared with 2023 (2.34 per 100 000). The cases were distributed across a wide age range, with the highest proportion (63.00%) occurring in the 5-9 years age group. Among the 2 830 cases aged <1 year, the highest proportion (42.76%) was observed in infants aged 3-5 months. Among the 7 826 cases reported after July 1, 2024, 1 513 (19.33%) were hospitalized, including 1 507 general hospitalizations and 6 intensive care unit (ICU) admissions. Among the ICU cases, 5 cases were aged <1 year. The hospitalization rate of pertussis differed significantly across age groups (P<0.001), with the highest rates observed in those aged ≥81 years (77.27%), 71-80 years (62.50%), and <1 year (56.20%), and the lowest rate in those aged 31-40 years (5.78%). The Cochran-Armitage trend test showed that as the number of DTP vaccine doses increased, the hospitalization rate of pertussis exhibited a decreasing trend (Z=-20.33, P<0.001). Multivariate logistic regression analysis revealed that after adjusting for age and sex, each additional dose of DTP vaccine was associated with a 25% reduction in the risk of hospitalization (aOR=0.75, 95%CI: 0.69-0.80). Conclusion: The reported incidence of pertussis in Zhejiang Province increases substantially in 2024, with school-aged children aged 5-9 years being the main affected population. Infants aged <1 year and elderly individuals are at higher risk of hospitalization after onset, and completing more doses of DTP vaccination can reduce the risk of hospitalization. 目的: 分析浙江省2024年百日咳流行病学特征和住院情况。 方法: 通过中国疾病预防控制信息系统和浙江省免疫规划智慧服务信息系统,收集2024年1月1日至12月31日浙江省百日咳报告病例个案资料及其百白破疫苗(DTP)接种信息。采用描述性流行病学方法分析病例的流行病学特征和住院情况;采用Cochran-Armitage趋势检验分析住院率随疫苗接种剂次变化的趋势,进一步采用多因素logistic回归模型,探究疫苗接种剂次与百日咳住院率的关系。 结果: 2024年浙江省共报告百日咳病例59 917例,发病率为90.42/10万,较2023年(2.34/10万)上升了37.64倍。病例年龄分布广泛,其中5~9岁组病例数最多(63.00%);在2 830例<1岁组病例中,3~5月龄婴儿病例数最多(42.76%)。2024年7月1日后报告的7 826例病例中,住院病例1 513例(19.33%),其中普通住院1 507例,重症监护病例6例;重症监护病例中,<1岁组5例。百日咳病例住院率在不同年龄组间差异有统计学意义(P<0.001),≥81岁、71~80岁、<1岁组住院率分别为77.27%、62.50%、56.20%,31~40岁组最低仅为5.78%。Cochran-Armitage趋势检验分析结果显示,随着DTP接种剂次增加,百日咳病例住院率呈下降趋势(Z=-20.33,P<0.001)。多因素logistic回归模型分析显示,调整年龄和性别后,每多接种1剂DTP疫苗,住院风险降低约25%(aOR=0.75,95%CI:0.69~0.80)。 结论: 浙江省2024年百日咳报告发病率大幅上升,5~9岁学龄儿童为主要发病人群;<1岁儿童和老年人发病后住院风险较高,完成更多剂次DTP接种可降低住院风险。.
引用
- Ding LL, Zhou Y, Zhu Y, et al. [Epidemiological characteristics and hospitalization status of pertussis in Zhejiang Province, 2024]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 42128676. doi:10.3760/cma.j.cn112150-20250528-00493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。